Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

9.4K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.4K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

398
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
398
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

403
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
403
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

582
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
582
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

728
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
728
Crossover Experiments01:16

Crossover Experiments

4.8K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors Influencing Visual and Refractive Outcomes for Scleral-Sutured Intraocular Lenses.

Journal of vitreoretinal diseases·2026
Same author

Genetic predisposition to malignancy confers different outcomes in malignant cutaneous melanoma: A retrospective cohort matched study using TriNetX.

Journal of the American Academy of Dermatology·2026
Same author

Impact of Transcatheter or Surgical Mitral Repair on Arrhythmic Burden in Patients With Mitral Valve Prolapse.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Repeat multiplex PCR gastrointestinal panel testing within 14 days yields minimal additional diagnostic information: a multicenter cohort study.

Infection control and hospital epidemiology·2026
Same author

Antibiotics prior to immune checkpoint inhibitor therapy worsens survival in Merkel cell carcinoma: A TriNetX retrospective cohort study.

Journal of the American Academy of Dermatology·2026
Same author

Preoperative predictors of adverse pathology and recurrence-free survival for patients with renal masses.

BJUI compass·2026
Same journal

Asymptotic online FWER control for dependent test statistics.

Statistical methods in medical research·2026
Same journal

Regression analysis of misclassified current status data with potentially unknown test accuracy.

Statistical methods in medical research·2026
Same journal

Bayesian multivariate linear mixed-effects models with varied association structures.

Statistical methods in medical research·2026
Same journal

Inference about the ratio of age-standardized rates between two overlapping populations.

Statistical methods in medical research·2026
Same journal

A robust neural network with random effects for subject-specific prediction of clustered count data.

Statistical methods in medical research·2026
Same journal

A comparison of methods for designing hybrid type 2 cluster-randomized trials with continuous effectiveness and implementation endpoints.

Statistical methods in medical research·2026
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.8K

A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trials.

Amy S Nowacki1, Wenle Zhao2, Yuko Y Palesch2

  • 11 Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, USA.

Statistical Methods in Medical Research
|January 15, 2015
PubMed
Summary
This summary is machine-generated.

Response-adaptive randomization (RAR) trials can be improved using surrogate outcomes. A novel surrogate-primary (S-P) replacement algorithm stabilizes treatment allocation faster when primary outcomes are delayed, preserving trial power.

Keywords:
Response-adaptive randomizationclinical trialsrandomizationsurrogate endpointsunequal allocation

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

430

Related Experiment Videos

Last Updated: Apr 18, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.8K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

430

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Neurology

Background:

  • Response-adaptive randomization (RAR) optimizes clinical trial performance by adjusting treatment allocation probabilities.
  • While delayed primary outcomes in RAR are studied, the use of surrogate outcomes remains underexplored.
  • Acute stroke trials present unique challenges due to delayed primary outcome assessment.

Purpose of the Study:

  • To explore the benefits and limitations of using surrogate outcomes in RAR for acute stroke trials.
  • To propose and evaluate a novel surrogate-primary (S-P) replacement algorithm.
  • To compare the S-P algorithm with complete randomization and standard RAR under various simulation scenarios.

Main Methods:

  • Development of a surrogate-primary (S-P) replacement algorithm for RAR.
  • Computer simulations to assess algorithm performance under delayed primary outcomes and outcome discrepancies.
  • Comparison of S-P algorithm against complete randomization and standard RAR.

Main Results:

  • The S-P replacement algorithm significantly reduces variability in treatment allocation probabilities when primary outcomes are delayed.
  • The S-P algorithm achieves faster stabilization of allocation probabilities compared to standard RAR.
  • Simulations demonstrated that the S-P algorithm preserves statistical power and reduces the expected number of trial failures.

Conclusions:

  • The proposed S-P replacement algorithm enhances RAR by effectively utilizing surrogate outcomes for delayed primary endpoints.
  • This approach offers a robust method to improve the efficiency and ethical conduct of acute stroke clinical trials.
  • The S-P algorithm provides a valuable tool for optimizing clinical trial design when primary outcome data is not immediately available.